“Evaluation of the EndoChoice full spectrum endoscopy (Fuse) platform for upper endoscopy and colonoscopy”

ABSTRACT

Traditional forward-viewing (TFV) flexible gastrointestinal endoscopes currently used to perform esophagogastroduodenoscopy (EGD) and colonoscopy have changed relatively little in the past two decades. While considered the standard of care, TFV endoscopes only allow between a 140-170° field of view (FOV). A revolutionary new endoscopic technology, “full spectrum endoscopy (Fuse)”, now allows a panoramic 245^o (gastroscope) to 330° (colonoscope) FOV. With this new endoscopic platform, physicians are able to view formerly difficult- or impossible-to-view areas within the gastrointestinal (GI) tract, such as behind the pylorus/within the duodenal bulb or the proximal side of colonic folds/flexures.

KEYWORDS:

• Endoscope
• gastroscope
• colonoscope
• colonoscopy
• gastrointestinal endoscopy
• endoscopic technology
• endoscopic innovation
• full spectrum endoscopy
• adenomas
• adenoma detection
• adenoma detection rate
• adenoma miss rate
• colorectal cancer
• CRC
• CRC screening
• interval cancer
• colonic folds
• pyloric folds
• pylorus

Financial & competing interests disclosure

IM Gralnek acts as a consultant at Endochoice. This work was partially funded by Endochoice. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.